Categories Editor's Pick
Categories Editor's Pick
Maduro trapped with few retaliation options after Trump admin seizes Venezuelan oil tanker
December 13, 2025
The Trump administration’s latest offensive move against Venezuela, the seizure of a tanker carrying U.S.-sanctioned oil, has triggered predictable outrage from Venezuelan
Categories Editor's Pick
Categories Editor's Pick
MIKE DAVIS: Why DC’s Trump-hating Judge Boasberg must be impeached
December 13, 2025
James Boasberg, the chief judge of the United States District Court for the District of Columbia and a Biden appointee,
Categories Investing
Rio Silver Closes the Acquisition of the Maria Norte Ag-Au-Pb-Zn Property in Central Peru
December 13, 2025
Rio Silver Inc. (the ‘Company’ or ‘Rio Silver’) (TSX.V: RYO,OTC:RYOOF) (OTC: RYOOF) announces that, following regulatory approval, the closing of the previously-announced
Categories Investing
Spartan Metals Terminates Investor Relations Agreement
December 13, 2025
(TheNewswire) Vancouver, Canada, December 12, 2025 TheNewswire – Spartan Metals Corp. (‘ Spartan ‘ or the
Categories Investing
Editor’s Picks: Silver Price Sets New Record as Fed Cuts Rates, Gold Retakes US$4,300
December 13, 2025
2025 is drawing to a close, and silver seems determined to end the year with a bang. The white metal’s breakout continued
Categories Editor's Pick
Republican House leader signals plan to begin contempt proceedings against Bill and Hillary Clinton
December 13, 2025
GOP House Oversight Committee Chairman James Comer said he plans to commence contempt of Congress proceedings against Bill and Hillary Clinton for
Categories Investing
Sun Summit Announces Upsized Non-Brokered Private Placement of up to $11.5 Million
December 13, 2025
Sun Summit Minerals Corp. (TSXV: SMN,OTC:SMREF) (OTCQB: SMREF) (‘Sun Summit’ or the ‘Company’) is pleased to announce that, due to significant investor demand, it
Categories Investing
InMed Provides Update on BayMedica Commercial Business
December 13, 2025
InMed Pharmaceuticals Inc. (NASDAQ: INM) (‘InMed’ or the ‘Company’), a pharmaceutical company focused on developing a pipeline of proprietary small molecule drug